• Understanding the Critical Role of Lupus Clinical Trial Outcome Measures in Advancing Therapeutic Development

  • Jul 1 2024
  • Length: 20 mins
  • Podcast

Understanding the Critical Role of Lupus Clinical Trial Outcome Measures in Advancing Therapeutic Development

Listen for free

View show details

  • Summary

  • Join Dr. Anna Wolska from the Lupus Foundation of America and Dr. Laurent Arnaud, Professor of Rheumatology at the Department of Rheumatology, University Hospitals of Strasbourg as they discuss systemic lupus erythematosus (SLE) clinical trials. In this episode, Dr. Arnaud highlights the complexities of drug approval processes in lupus, the pivotal role of large-scale phase three randomized trials and critical outcome measures in these trials, from primary endpoints assessing treatment efficacy to secondary and exploratory measures capturing broader impacts on patient health and quality of life.

    Read the article: https://lupus.bmj.com/content/11/1/e001114
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Understanding the Critical Role of Lupus Clinical Trial Outcome Measures in Advancing Therapeutic Development

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available